Baltazar D. Sanabria
Campo Grande, MS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial.
Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: August 06, 2025
Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 23, 2024
Prospective evaluation of blood pressure, heart rate, and side effects in hypertensive patients using low-dose oral minoxidil for hair loss.
Journal: Journal of the American Academy of Dermatology
Published: April 04, 2024
Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring.
Journal: Anais brasileiros de dermatologia
Published: June 07, 2023
Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5-mg oral minoxidil for androgenetic alopecia.
Journal: Journal of the American Academy of Dermatology
Published: March 02, 2022
Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
Journal: Journal of the American Academy of Dermatology
Published: August 25, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026